Showing 11-15 of 36 payers:
Validation of a machine learning approach to estimate expanded disability status scale scores for multiple sclerosis

Sage Journals Published June 22, 2022 Read the Full Manuscript>>  Abstract Background Disability assessment using the Expanded Disability Status Scale (EDSS) is important to inform treatment decisions and monitor the progression of multiple sclerosis. Yet, EDSS scores are documented infrequently in electronic medical records. Objective To validate a machine learning model to estimate EDSS scores[…]

OM1 Launches New Mental Health and Neuroscience Real-World Data Network

Read the Press Release>>   BOSTON, March 31, 2022 /PRNewswire/ — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric[…]

Real-World Evidence Analysis Of The Impact Of Steroid-Eluting Implants On Healthcare Resource Use Among Chronic Rhinosinusitis Patients Undergoing Sinus Surgery

Taylor & Francis Online Published: January 20, 2022 Read the Full Manuscript >> Objective To compare healthcare resource use (HCRU) in patients undergoing sinus surgery with or without steroid-eluting sinus implants. Methods A retrospective, observational cohort study using real-world evidence data (OM1, Inc, Boston, MA, USA) was conducted on adult patients with chronic rhinosinusitis (CRS)[…]

RWD + External Control Arms for Clinical Trials & Regulatory

Wed, Sep 29, 2021 11:00 AM – 12:00 PM EDT Presenter: Richard Gliklich, MD, CEO, OM1 Register >> Real-world data (RWD) is increasingly being used to develop external control arms (ECA) for trial planning and regulatory submissions. But, what types of RWD is needed and how should it be applied to be successful? Join Dr.[…]

1 2 3 4 5 … 8